Shelo Nabel Therapygel
FDA Label NDC 71424-1061

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Corporativo Serysi S De R L De C V for the product Shelo Nabel Therapygel (NDC 71424-1061). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient u061, inactive ingredient u061, warnings u061, uses u061, kroc u061, admon u061, indications u061, display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.